841
Participants
Start Date
November 30, 2011
Primary Completion Date
August 31, 2016
Study Completion Date
August 31, 2016
Tiotropium
18 mcg tiotropium capsule, once daily, inhaled by HandiHaler, for 24 months
placebo
placebo, once daily, inhaled by HandiHaler
Beijing Chao-Yang Hospital, Beijing
Shanghai Xuhui District Central Hospital, Shanghai
Zhongshan Hospital Fudan University, Shanghai
The Second People's Hospital of Hunan Province, Changsha
Chenzhou No.1 people's Hopital, Chenzhou
Tongji Hospital,Tongji Medical College of HUST, Wuhan
Henan Provincial People's Hospital, Zhengzhou
The First Affiliated Hospital of Sun Yat-sen University, Guangzhou
The First Affiliated Hospital of Guangzhou Medical College, Guangzhou
Liwan Hospital,Guangzhou Medical College, Guangzhou
The Third Affiliated Hospital of Guangzhou Medical College, Guangzhou
Guangdong No.2 Provincial People's Hospital, Guangzhou
The First Affiliated Hospital of Jinan University, Guangzhou
Guangzhou Panyu Center Hospital, Guangzhou
The First People's Hospital of Shaoguan, Shaoguan
Shaoguan Iron and Steel Group Company limited Hospital, Shaoguan
Huizhou First Hospital, Huizhou
Shenzhen Sixth People's Hospital, Shenzhen
The second people's Hospital,Zhanjiang, Zhanjiang
Affiliated Hospital of Guangdong Medical College, Zhanjiang
The First People's Hospital of Foshan, Foshan
The Affiliated Hospital of Guiyang Medical College, Guiyang
Guizhou People's Hospital, Guiyang
Xinqiao Hospital, Chongqing
Wengyuan County People's Hospital, Shaoguan
Collaborators (1)
Boehringer Ingelheim
INDUSTRY
Rundo International Pharmaceutical Research & Development Co.,Ltd.
INDUSTRY
The First Affiliated Hospital of Guangzhou Medical University
OTHER